welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

US Politics

US Politics

Merck & Co., Inc. (MRK): Among Value Stocks in Ken Fisher’s Portfolio

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

73% Informative

Merck & Co. , Inc. ( NYSE :MRK) is a healthcare company that focuses on delivering innovative solutions through prescription medicines, animal products and animal health products.

While the stock has pulled back significantly, it remains a top stock-value stock in Ken Fisher’s portfolio as it is trading at a price-to-earnings of 849 .

Merck & Co. , Inc. ( NYSE :MRK) has moved to reinvigorate its growth metrics with a $493 million licensing deal with Austria -based drug delivery technology maker Cyprumed on April 15 .

Overall, MRK ranks 8th on our list of value stocks in Ken Fisher’s portfolio.